80
Participants
Start Date
December 31, 2013
Primary Completion Date
August 31, 2017
Study Completion Date
February 28, 2018
Cisplatin
Cisplatin 60 mg/m2 as a 1 hour i.v. infusion once every 3 weeks.
5-Fluorouracil (5-FU)
5-FU 1000 mg/m2/24h as a 96-hour continuous infusion over days 1 to 4 every 3 weeks.
Carboplatin
Carboplatin 1-hour i.v. infusion to an area under the curve (AUC) of 5 once every 4 weeks.
Paclitaxel
Paclitaxel 80 mg/m2 as a 1-hour i.v. infusion on day 1,8 and 15 of each (4-weekly) cycle.
NOT_YET_RECRUITING
Laura Gagnon, Boston
NOT_YET_RECRUITING
Margot Gorzeman, Sydney
RECRUITING
Royal Marsden NHS Foundation Trust, London & Sutton, Sutton
Collaborators (1)
Cancer Research UK
OTHER
Australasian Gastro-Intestinal Trials Group
NETWORK
ECOG-ACRIN Cancer Research Group
NETWORK
European Organisation for Research and Treatment of Cancer - EORTC
NETWORK
International Rare Cancers Initiative (IRCI ) This study is indorsed by IRCI
UNKNOWN
Royal Marsden NHS Foundation Trust
OTHER